OBJECTIVE: To evaluate the effect of hormonal replacement therapy (HRT) regimens in surgical @entity7793 @entity1 with underlying @entity46 . DESIGN: Observational retrospective study. MATERIAL AND METHOD: 123 @entity1 with @entity46 after definite surgery (total abdominal hysterectomy with bilateral salpingo-oophorectomy) were followed in the Gynecologic Endocrinology and Menopause clinics. @entity1 were classified into 4 groups according to HRT regimens, i.e. control (no HRT, n=17), @entity172 only (ERT, n=50), cyclic @entity172 /progestin regimen (cyclic E/P, n=16), and continuous combined @entity172 /progestin (ccE/P, n=24). 12 @entity1 who received more than one regimen and 4 @entity1 who received less than 6 months of HRT were excluded from the study. The information was obtained from the medical records. RESULTS: Mean age at surgery of all @entity1 was 38.9 years old. Mean duration of HRT was 41.2 months. There was no difference in age at surgery or duration of follow-up in each group. There was 1 (2%) case of recurrent @entity46 and 3 (6%) cases of recurrent symptoms in the @entity172 only group; none of them required additional surgical treatment. Malignant transformation was not found. CONCLUSIONS: Although the present series is small, it seems that HRT is safe for postmenopausal @entity1 with underlying @entity46 . Recurrence of @entity46 has rarely been a problem with HRT, especially in those who received the combination of @entity172 and @entity1871 regimens.

Hormonal replacement therapy in surgical @entity7793 with underlying XXXX .

@entity1 :: ('9606', 'Species') :: ['women', 'Patients', 'patients'] @entity172 :: ('MESH:D004967', 'Chemical') :: ['estrogen'] @entity7793 :: ('MESH:D008594', 'Disease') :: ['menopause'] @entity1871 :: ('CHEBI:59826', 'Chemical') :: ['progestin'] @entity46 :: ('MESH:D004715', 'Disease') :: ['endometriosis']
@entity46 :: (MESH:D004715,Disease) :: ['endometriosis']
